Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Jean‐Nicolas Vauthey et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancerZhengqi Cao, Ziming Li, Zhouwenli Meng et al.|Cell Reports Medicine|2025Cited by 19